Borosil Scientific Limited Promoters Declare NIL Encumbrance on Shares for FY26

Borosil Scientific Limited promoters have submitted a formal declaration under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, confirming that no encumbrance was created on any promoter-held equity shares during the financial year ended March 31, 2026. The declaration was filed by Pradeep Kumar Kheruka on behalf of himself and all other promoters and persons acting in concert (PAC). The filing was addressed to BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited.

Key Declaration Highlights

The declaration confirms that the promoters, along with persons acting in concert, have not made any encumbrance, directly or indirectly, on the equity shares held by them in Borosil Scientific Limited during the financial year ended March 31, 2026. As on March 31, 2026, NIL equity shares of Borosil Scientific Limited are encumbered by the promoters or PAC.

Parameter: Details Regulation: Regulation 31(4), SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Financial Year: Ended March 31, 2026 Encumbrance During FY26: NIL Encumbered Shares as on March 31, 2026: NIL Filed By: Pradeep Kumar Kheruka (Promoter) Date of Filing: April 02, 2026

Persons Acting in Concert

The declaration covers the following promoters and persons acting in concert (PAC) of Borosil Scientific Limited:

Kiran Kheruka

Rekha Kheruka

Pradeep Kumar Kheruka

Shreevar Kheruka

Gujarat Fusion Glass LLP

Spartan Trade Holdings LLP

Borosil Holdings LLP

Associated Fabricators LLP

Sonargaon Properties LLP

Croton Trading Private Limited

Alaknanda Ruia

Regulatory Compliance

This declaration is a mandatory annual compliance requirement under SEBI's Takeover Regulations, obligating promoters to confirm the status of encumbrance on their shareholding at the end of each financial year. The filing was submitted to both stock exchanges — BSE Limited and the National Stock Exchange of India Ltd — as well as to the Audit Committee of Borosil Scientific Limited, in accordance with the prescribed regulatory framework.

Borosil Scientific Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate was filed with both BSE Limited and the National Stock Exchange of India Limited on April 03, 2026.

Regulatory Compliance Certificate

The company's Registrar and Transfer Agent, MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited), issued the compliance certificate confirming that all securities of Borosil Scientific Limited remain in dematerialized form. The certificate covers the period from January 01, 2026 to March 31, 2026.

Certificate Details: Information Regulation: SEBI (Depositories and Participants) Regulations, 2018 Period Covered: January 01, 2026 to March 31, 2026 Filing Date: April 03, 2026 Registrar: MUFG Intime India Private Limited

Key Compliance Confirmation

The certificate specifically confirms that no Demat/Remat requests were received during the quarter from any of the depositories. This indicates that all equity shares of the company continue to be held in electronic form, maintaining full compliance with regulatory requirements for listed companies.

Stock Exchange Filing

The compliance certificate was simultaneously filed with both stock exchanges where Borosil Scientific shares are listed. The company's shares trade on BSE Limited under scrip code 544184 and on the National Stock Exchange of India Limited under the trading symbol BOROSCI.

Exchange Details: Information BSE Scrip Code: 544184 NSE Trading Symbol: BOROSCI Company CIN: L74999MH1991PLC061851 Filing Officer: Sanjay Gupta, Company Secretary

Corporate Information

Sanjay Gupta, Company Secretary and Compliance Officer (ICSI Membership No.: A24641), signed the filing on behalf of Borosil Scientific Limited. The company's registered and corporate office is located at 1101, Crescenzo, G-Block, Opp. MCA Club, Bandra Kurla Complex, Bandra(E), Mumbai-400 051.

This quarterly compliance filing demonstrates the company's adherence to regulatory requirements and maintains transparency with stakeholders regarding the status of its securities in the depository system.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.